Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: Normalizing effect of dehydroepiandrosterone sulfate

European Journal of Endocrinology

Volumn 152, Issue 5, 2005, Pages 703-712

  Solerte, Sebastiano Bruno ^a   Precerutti, Sara ^a,b   Gazzaruso, Carmine ^b   Locatelli, Eleonora ^a   Zamboni, Mauro ^b   Schifino, Nicola ^c   Bonacasa, Roberto ^c   Rondanelli, Mariangela ^c   Taccani, Davide ^a   Ferrari, Ettore ^a   Fioravanti, Marisa ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Geriatric Rehabilitative Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETANTRONE; CD16 ANTIGEN; CD56 ANTIGEN; CYTOKINE; LEVOTHYROXINE; PRASTERONE SULFATE; RECOMBINANT BETA INTERFERON; RECOMBINANT INTERLEUKIN 2; THIAMAZOLE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL DENSITY; CELL SEPARATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DRUG EFFECT; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOMAGNETIC SEPARATION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; T LYMPHOCYTE; VALIDATION PROCESS;

ADJUVANTS, IMMUNOLOGIC; ADULT; DEHYDROEPIANDROSTERONE SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAVES DISEASE; HUMANS; INTERFERON-BETA; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; THYROIDITIS, AUTOIMMUNE;

EID: 21144464956     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01906     Document Type: Article

References (54)

1. Herberman RB & Ortaldo JR. Natural killer cells: their role in defences against disease. Science 1981 214 24-30.
2. Robertson MJ & Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990 76 2421-2438.
3. Bonnema JD, Rivlin KA, Ting AT, Schoon RA, Abraham RT & Leibson PJ. Cytokine enhanced NK cell mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. Journal of Immunology 1994 152 2098-2104.
4. Gidlund M, Orn A, Wigzell H, Senik A & Gresser I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 1978 273 759-761.
5. Trinchieri G & Santoli D. Enhancement of human natural killer cell activity by interferon. Journal of Immunology 1978 120 1845-1850.
6. Henney CS, Kuribayashi K, Kern DE & Gillis S. Interleukin-2 augments natural killer cell activity. Nature 1981 291 335-337.
7. Trinchieri G, Kobayashi M, Seehra J, London L & Perussia B. Response of resting human peripheral blood natural killer cells to interleukin 2. Journal of Experimental Medicine 1984 160 1147-1169.
8. Baxter AG & Smyth MJ. The role of NK cells in autoimmune disease. Autoimmunity 2002 35 1-14.
9. Yabuhara A, Yang FC, Nakazawa T, Iwasaki Y, Mori T, Koike K, Kawai H & Komiyama A. A killing defect of natural killer cells as an underlying immunological abnormality in childhood systemic lupus erythematosus. Journal of Rheumatology 1996 23 171-177.
10. Goto M, Tanimoto K, Chihara T & Horiuchi Y. Natural cell-mediated cytotoxicity in Sjogren's syndrome and rheumatoid arthritis. Arthritis and Rheumatism 1981 24 1377-1382.
11. Hauser SL, Ault US, Levin MJ, Garovoy MR & Weiner HL. Natural killer cell activity in multiple sclerosis. Journal of Immunology 1981 127 1114-1117.
12. Auer IO, Ziemer E & Sommer H. Immune status in Crohn's disease. Clinical and Experimental Immunology 1980 42 41-47.
13. Stassi G & De Maria R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nature Reviews. Immunology 2002 2 195-204.
14. Itoh M, Uchimura K, Makino M, Kobayashi T, Hayashi R, Nagata M, Kakizawa H, Fujiwara K & Nagasaka A. Production of IL-10 and IL-12 in CD40 and interleukin-4 activated mononuclear cells from patients with Graves' disease. Cytokine 2000 12 688-693.
15. Massart C, Caroff G, Maugendre D, Genetet N & Gibassier J. Peripheral blood and intrathyroidal T cell clones from patients with thyroid autoimmune disease. Autoimmunity 1999 31 163-174.
16. Heuer M, Aust G, Ode-Hakim S & Scherbaum WA. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996 6 97-106.
17. Mori H, Amino N, Iwatani Y, Izumiguchi Y, Kumahara Y & Miyai K. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. Journal of Clinical Endocrinology and Metabolism 1982 55 399-402.
18. Amino N, Mori H, Iwatani Y, Asari SI, Zumiguchi YI & Myiai K. Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves' disease and increase in Hashimoto's disease. Journal of Clinical Endocrinology and Metabolism 1982 54 587-591.
19. Sawada K, Saturami T, Imura H, Iwamori M & Nabai Y. Antiasialo-GMI antibody in sera from patients with Graves' disease and Hashimoto's thyroiditis [letter]. Lancet 1980 2 198.
20. Pruzanski W, Capes H, Baur R, Wenzel BE, Row VV & Volpe R. Biological activity of lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditis. Journal of Endocrinological Investigations 1984 7 7-13.
21. Calder EA, Irvine WJ, Davidson NM & Wu FT. B and K cells in autoimmune thyroid disease. Clinical Experimental Immunology 1976 25 17-23.
22. Tezuka H, Eguchi K, Fukuda T, Otsubo T, Kawabe Y, Ueki Y, Matsunaga M, Shimamura C, Nalao H & Ishikawa N. Natural killer and natural killer-like activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism 1988 66 702-707.
23. Pedersen BK, Feldt-Rasmussen U, Bech K, Perrild H, Klarlund K & Hoier-Madsen M. Characterization of the natural killer activity in Hashimoto's and Graves' diseases. Allergy 1989 44 477-481.
24. Wenzel B, Chow A, Schleusener H & Wall JR. NK cell activity in autoimmune thyroid disorders. Proceedings of the 57th Annual Meeting of the American Thyroid Association, Minneapolis 1981. Abstract T26.
25. Papic M, Stein-Streilein J, Zakarija M, McKenzie JM, Guffee J & Fletcher AM. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. Journal of Clinical Investigation 1987 79 404-408.
26. Wang PW, Luo SF, Huang BY, Lin JD & Huang MJ. Depressed natural killer cell activity in Graves' disease and during antithyroid medication. Clinical Endocrinology 1988 28 205-214.
27. Marazuela M, Vargas JA, Alvarez-Mon M, Albarran F, Lucas T & Durantez A. Impaired natural killer cell cytotoxicity in peripheral blood mononuclear cells in Graves' disease. European Journal of Endocrinology 1995 132 175-180.
28. Hidaka Y, Amino N, Iwatani Y, Kaneda T, Nasu M, Mitsuda N, Tanizawa O & Miyai K. Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Autoimmunity 1992 11 239-246.
29. Wenzel BE, Chow A, Baur R, Schleusener H & Wall JR. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis. Thyroid 1998 8 1019-1021
30. Manzano, L, Alvarez-Mon M, Abreu L, Vargas JA, Morena E, Corugedo F & Durantez A. Functional impairment of natural killer cells in active ulcerative colitis: reversion of the detective natural killer activity by interleukin 2. Gut 1992 33 246-251.
31. Flodstrom M, Shi FD, Sarvetnick N & Ljunggren HG. The natural killer cell - friend or foe in autoimmune disease? Scandinavian Journal of Immunology 2002 55 432-441.
32. Bolay H, Karabudak R, Aybay C, Candemir H, Varli K, Imir T & Kansu E. Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity. Journal of Neuroimmunology 1998 82 109-115.
33. van Vollenhoven RF. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opinion on Pharmacotherapy 2002 3 23-31.
34. Khorram O, Vu L & Yen SS. Activation of immune function by dehydroepiandrosterone (DREA) in age-advanced men. Journal of Gerontology 1997 52 M1-M7.
35. Nawata H, Yanase T, Goto K, Okabe T & Ashida K. Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S. Mechanisms of Ageing and Development 2002 123 1101-1106.
36. Solerte SB, Fioravanti M, Vignati G, Giustina A, Cravello L & Ferrari E. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. Journal of Clinical Endocrinology and Metabolism 1999 84 3260-3267.
37. Solerte SB, Fioravanti M, Schifino N, Cuzzoni G, Fontana I, Vignati G, Govoni S & Ferrari E. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type. Dementia and Geriatric Cognitive Disorders 1999 10 21-27.
38. Van Zoelen EJ, Van Oostwaard TM, Van der Saag PT & De Laat SW. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor. Journal of Cell Physiology 1985 123 151-160.
39. Timonen T, Ranki A, Saksele E & Hayry P. Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cellular Immunology 1979 48 133-139.
40. Robertson MJ & Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990 76 2421-2438.
41. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scandinavian Journal of Clinical and Laboratory Investigation 1968 21 (Suppl) 31-50.
42. Julius MH, Simpson E & Herzenberg LA. A rapid method for isolation of functional thymus-derived murine lymphocytes. European Journal of Immunology 1973 3 645-649.
43. Miltenyi S, Muller W, Weichel W & Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990 11 231-238.
44. Pflueger E, Mueller EA & Anderer FA. Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic bead. Journal of Immunological Methods 1990 129 165-173.
45. Gatti G, Cavallo R, Sartori ML, Del Ponte D, Masera R, Salvadori A, Carignola R & Angeli A. Inhibition by cortisol of human natural killer (NK) cell activity. Journal of Steroid Biochemistry 1987 26 49-58.
46. Holbrook NJ, Cox WI & Horner HC. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Research 1983 43 4019-4025.
47. Korzeniewski C & Callewaert DM. An enzyme-release assay for natural cytotoxicity. Journal of Immunological Methods 1983 64 313-320.
48. Pross HF, Baynes MG, Rubin P, Shragge P & Patterson MS. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantification of natural killer cell activity. Journal of Clinical Immunology 1981 1 51-63.
49. Solovera J, Alverez-Mon M, Casas J, Carballido J & Durantez A. Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist. Journal of Immunology 1987 139 876-880.
50. Weetman AP, Gunn C, Hall R & McGregor AM. The absence of any effect of methimazole on in vitro cell-mediated cytotoxicity. Clinical Endocrinology 1985 22 57-64.
51. Ciampolillo, A, Guastamacchia E, Amati L, Magrone T, Munno I, Jirillo E, Triggiani V, Fallacara R & Tafaro E. Modifications of the immune responsiveness in patients with autoimmune thyroiditis: evidence for a systemic immune alterations. Current Pharmaceutical Design 2003 9 1946-1950.
52. Daynes RA, Dudley DJ & Araneo BA. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin-2 synthesis by helper cells. European Journal of Immunology 1990 20 793-802.
53. Suzuki T, Suzuki N, Daynes RA & Engleman EG. Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T-cells. Clinical Immunology and Immunopathology 1991 61 202-211.
54. Solerte SB, Cravello L, Ferrari E & Fioravanti M. Overproduction of IFN-γ and TNF-α from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease. Annals of the New York Academy of Sciences 2000 917 331-340.